Company / EPS (Diluted)
Ceribell, Inc. EPS (Diluted) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.46
FY2025
5-year range
-$5.56 / -$1.46
FY2023-FY2025
Trend
+73.7%
vs FY2024
Sector context
#136 of 159
Health Care
What the data says
Ceribell, Inc.'s eps (diluted) of $-1.46 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $-5.56 to $-1.46 over the past 2 years.
Based on SEC 10-K filings.
-1.46 in FY2025.
Improved from $-5.56 to $-1.46 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 159This company -$1.46 Sector average $2.35
▼
-162.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 73.7% year-over-year.
- Ranks #136 out of 159 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.46 | +73.7% |
| FY2024 | -$5.56 | +0.0% |
| FY2023 | -$5.56 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026